Corporations
Shareholder Derivative
Acquistion, Misrepresentation
Biotechnology Value Fund LP, Biotechnology Value Fund II, LP, Investment 10 LLC, BVF Investments LLC, BVF Inc., BVF X LLC v. Celera Corporation, Quest Diagnostics Inc., Credit Suisse Securities (USA) LLC, Kathry Ordonez, Richard H. Ayers, Jean-Luc Belingard, William G. Green, Peter Barton Hutt, Gail M. Naughton, Wayne I. Roe, and Bennett M. Shapiro
Published: Jan. 18, 2014 | Result Date: Dec. 20, 2013 | Filing Date: Jan. 1, 1900 |Case number: 3:13-cv-03248-WHA Bench Decision – Dismissal
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Already a subscriber?
Sign In